QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
QQQ   424.06 (-0.42%)
AAPL   167.20 (-0.48%)
MSFT   405.19 (-1.61%)
META   503.38 (+1.86%)
GOOGL   156.45 (+0.63%)
AMZN   179.55 (-0.95%)
TSLA   150.45 (-3.22%)
NVDA   849.20 (+1.05%)
AMD   154.94 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.96 (+0.20%)
T   16.31 (+1.18%)
F   12.05 (+0.08%)
MU   112.52 (-3.28%)
GE   153.77 (-1.22%)
CGC   7.87 (+21.26%)
DIS   112.76 (-0.16%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.08 (-1.87%)
XOM   118.72 (+0.08%)
TSE:PRN

Profound Medical (PRN) Price, Holdings, & News

C$10.67
-0.02 (-0.19%)
(As of 03:51 PM ET)
Today's Range
C$10.44
C$10.79
50-Day Range
C$10.69
C$12.51
52-Week Range
C$9.55
C$20.44
Volume
4,100 shs
Average Volume
5,095 shs
Market Capitalization
C$260.67 million
Assets Under Management
C$131.70 million
Dividend Yield
0.72%
Net Expense Ratio
0.60%
PRN stock logo

About Profound Medical (TSE:PRN)

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

PRN Stock Price History

PRN ETF News Headlines

PROF Apr 2024 7.500 call
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
PROF Mar 2024 10.000 call
PROF Mar 2024 10.000 put
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
See More Headlines
Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Invesco
Fund Name
Invesco DWA Industrials Momentum ETF
Tax Classification
Regulated Investment Company
Inception Date
10/12/2006
Fund Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon

Fund Focus

Asset Class
Equity
Benchmark
DWA Industrials Technical Leaders Index
Category
Sector
Focus
Industrials
Development Level
Developed Markets
Region
North America
Number of Holdings
45

Fund Statistics

Assets Under Management
$131.70 million
Average Daily Volume
$18,993.80
Discount/Premium
-0.74%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Susquehanna

Miscellaneous

Beta
0.86
Creation Unit
50,000
Creation Fee
$500.00
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Profound Medical Expenses

TypePRNIndustrials ETFsEquity ETFsTSE ETFsAll ETFs
Management Fee0.50%0.52%0.54%0.65%0.51%
Other Expenses0.14%0.35%0.54%0.14%0.58%
Total Expense0.64%0.67%0.70%0.72%0.70%
Fee Waiver-0.04%-0.69%-0.55%-0.04%-0.57%
Net Expense0.60%0.56%0.60%0.70%0.58%

Profound Medical (PRN) Holdings & Exposure

PRN Sector Exposure

PRN Industry Exposure

Key Executives

  • Dr. Arun Swarup Menawat MBA (Age 69)
    Ph.D., Chairman of the Board & CEO
    Comp: $749.57k
  • Mr. Rashed Dewan (Age 56)
    Chief Financial Officer
    Comp: $340.06k
  • Dr. Mathieu Burtnyk (Age 42)
    Chief Operating Officer
    Comp: $334.26k
  • Mr. Hartmut Warnken (Age 51)
    Chief Commercial Officer of Outside US
    Comp: $305.5k
  • Mr. Abbey Goodman (Age 41)
    Chief Commercial Officer of US
    Comp: $480.47k
  • Mr. Stephen Kilmer
    Investor Relations
  • Mr. Jacques F. Cornet (Age 68)
    Senior VP & Product Leader Sonalleve
  • Mr. Matthew Sobczyk C.A.
    CPA, Assistant Corporate Controller
  • Mr. Levant Tinaz
    Software Developer

PRN ETF - Frequently Asked Questions

How have PRN shares performed in 2024?

Profound Medical's stock was trading at C$11.10 at the beginning of 2024. Since then, PRN shares have decreased by 4.1% and is now trading at C$10.65.
View the best growth stocks for 2024 here
.

When is Profound Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our PRN earnings forecast
.

How were Profound Medical's earnings last quarter?

Profound Medical Corp. (TSE:PRN) posted its quarterly earnings data on Thursday, March, 7th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.38) by $0.19. The firm had revenue of $2.74 million for the quarter, compared to analyst estimates of $2.56 million.

What does PRN invest in?

Profound Medical is a equity fund issued by Invesco. PRN focuses on industrials investments and follows the DWA Industrials Technical Leaders Index. The fund's investments total to approximately $131.70 million assets under management.

What stocks does Profound Medical hold?
What is the management fee for Profound Medical?

Profound Medical's management fee is 0.50% and has other expenses of 0.14%. However, PRN has a fee waiver of -0.04% to reimburse the expenses. The net expense ratio for PRN is 0.60%.

What other stocks do shareholders of Profound Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Profound Medical investors own include Orocobre (ORL), Ballard Power Systems (BLDP), Whitecap Resources (WCP), Alcanna (CLIQ), Just Energy Group (JE), Kezar Life Sciences (KZR), Lithium Americas (LAC), Russel Metals (RUS) and Absolute Software Co. (ABT.TO) (ABT).

How do I buy shares of Profound Medical?

Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:PRN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners